钆携带剂用于中子俘获治疗的现状及进展
State and Progress of Gadolinium-Based Agents for Neutron Capture Therapy
-
摘要: 钆中子俘获治疗(gadolinium neutron capture therapy, GdNCT)是一种基于热中子与钆(gadolinium, Gd)之间的俘获反应对肿瘤细胞产生损伤的新疗法。钆中子俘获治疗的优势在于,钆在所有自然元素中具有最高的热中子俘获截面;含钆造影剂广泛应用于核磁共振成像(magnetic resonance imaging, MRI)。为了提高GdNCT的治疗效果,已经有多种方法对钆携带剂进行改进。本文阐述了钆中子俘获治疗的原理,总结了提高钆携带剂在中子俘获治疗过程中治疗效果的多种策略,为将来GdNCT的临床应用提供新的思路。Abstract: Gadolinium neutron capture therapy(GdNCT) is an innovative treatment that exert damage on tumor cells based on the capture reaction between thermal neutron and gadolinium. In comparison with other types of neutron capture therapy(NCT), gadolinium has the highest thermal capture cross section of any natural elements. Gadoliniumbased agents are widely used in magnetic resonance imaging(MRI) as contrast agents. The improvements of multiple gadoliniumbased agents have been applied to enhance therapeutic efficacy of GdNCT. In this review, principles of gadolinium neutron capture therapy were studied and diverse strategies to improve therapeutic efficacy of gadoliniumbased agents were summarized. Giving a perspective on GdNCT to prompt its clinical use.